Speakers

Dr. Beth Kirkpatrick received her M.D. from Albany Medical College. She performed an internship, residency and chief residency in Internal Medicine at the University of Rochester, NY. Her Fellowship in Infectious Diseases was performed at Johns Hopkins University, which included training in both basic and clinical/translational research, as well as additional training in clinical tropical medicine. At a new faculty at the University of Vermont, Dr. Kirkpatrick founded the UVM Vaccine Testing Center (VTC) in 2002. The VTC is a multi-disciplinary team which performs phase I-III vaccine clinical trials, experimental human infectious models (enteric pathogens and flaviviruses), and clinical immunology- in the United States and in low-middle-income countries. She serves as principal investigator of UVM’s Center of Biomedical Research Excellence, the Translational Global Infectious Diseases Research (TGIR) center, as well as Chair of the Department of Microbiology and Molecular Genetics at the UVM College

of Medicine. With collaborators at the NIH and Johns Hopkins, Dr. Kirkpatrick and the UVM team have worked on NIH Dengue

vaccines since 2009, including evaluating multiple monovalent and tetravalent formulations, DENV2 and 3 challenge models, and

have performed both dengue vaccine trials and challenge models in Bangladesh.